Get SWN alerts

Share this content

Presbia PLC (NASDAQ:LENS)

As of today, October 31, 2018 at 9:06pm EST, Presbia PLC (NASDAQ:LENS) has 17.16M shares outstanding with a float of 9.49M.

Presbia PLC’s yearly revenue of $16K provides them a gross profit of -$83K. Their current share price is $0.72. LENS is in the Healthcare sector and Medical Instruments & Supplies industry.

lens

Profile:

Presbia is a medical device company focused on the development of the presbyopia-correcting Presbia Flexivue Microlens™ – an innovative solution for the common age-related loss of the ability to read or focus on near objects. The 3mm diameter lens is implanted in a corneal pocket created by a femtosecond laser. Learn more about the Microlens solution.

This solution responds to the market’s need for a surgical procedure that is safe, effective, quick and easy to learn and implement. The Presbia Flexivue Microlens™ solution relies on surgical equipment already in use at most eye surgery centers. Most distinguishing, the Presbia Flexivue Microlens™ is designed to be removable, meaning that the lens can be removed and replaced without any residual effect on the eye.

The Presbia Flexivue Microlens™ has received the CE mark for the European Economic Area, allowing the lens to be commercially available across Europe. The Presbia Flexivue Microlens™ has not been approved by the FDA and is not commercially available in the United States. Presbia is an ISO 13485 approved company.

Check out SOME latest tagged press releases:

Share this content

Get SWN alerts

Discovering Small Stocks Before They Make Their Big Move...

New to the  market? These emerging profiles may be worth researching for those beginning to explore small-caps.